脳イメージングモダリティ市場レポート：動向、予測、競合分析 (2031年まで)

世界の脳イメージングモダリティ市場の将来は、病院・診療所、画像診断センター、外来手術センター市場における機会で有望視されています。世界の脳イメージングモダリティ市場は、2025年から2031年までのCAGRが4.8%で、2031年までに推定185億米ドルに達すると予想されます。この市場の主な促進要因は、神経疾患と外傷性脳損傷の有病率の増加、脳イメージングモダリティとシステムの継続的な技術進歩、脳画像における分子イメージングの人気の高まりです。

• Lucintel社の予測によると、製品カテゴリーでは、脳腫瘍、脳卒中、多発性硬化症などの様々な病状を診断するためにMRI装置の採用が増加しているため、予測期間中にMRI装置が最も高い成長を遂げる見込みです。
• エンドユースカテゴリーでは、病院・診療所が引き続き最大セグメントです。
• 地域別では、神経疾患の有病率の上昇、新技術の強力な採用、同地域の主要脳イメージングモダリティメーカーの存在により、北米が予測期間を通じて最大地域であり続けます。

脳イメージングモダリティ市場の戦略的成長機会

脳イメージングモダリティ市場は、さまざまなサブマーケットを支配する主要アプリケーションに関連した戦略的成長機会に満ちています。これらは、診断、治療、研究における技術革新のために効果的に活用することができます。

• 神経変性疾患診断：神経変性疾患の早期診断とモニタリングを可能にする、より洗練された画像システムを設計する余地が広がっています。画像診断の強化により、アルツハイマー病やパーキンソン病などの神経変性疾患の診断と治療が、症状発現のかなり前に促進される可能性があります。
• 個別化医療：トレンドが個別化医療戦略へとシフトする中、こうしたアプローチに脳画像を統合することは、個々の脳に特化したカスタム治療への動きを示しています。このため、患者の状態や治療に対する反応を正確に描写する画像システムが必要とされています。
• 遠隔・携帯イメージングソリューション：遠隔地や持ち運び可能な脳画像ソリューションを提供する傾向が高まっており、診断目的のために十分なサービスを受けていない地域に到達するのに役立っています。遠隔地では、手頃な価格で使い勝手の良いイメージングシステムが必要とされており、大きな市場機会をもたらしています。
• マルチモーダルイメージングの統合：脳を総合的に評価するためにさまざまな画像診断技術を融合する能力は、開発の大きな可能性を秘めています。MRI、PET、CTなどの機器を統合することで、診断の向上、ひいては患者の転帰の改善が期待できます。
• 調査と臨床試験：脳画像分野における調査と臨床試験は、改善の余地を提供しつつあります。イメージング技術の開発が進めば、脳機能の解明やより効果的な治療法の開発における格差が縮小されます。

こうした戦略的成長機会が、脳イメージングモダリティ市場の将来を形成しています。利害関係者がイノベーションを促進し、診断状況を改善し、患者体験を向上させるためには、これらの分野に優先的に取り組む必要があります。

脳イメージングモダリティ市場の促進要因・課題

脳イメージングモダリティ市場は、技術向上、経済変動、規制政策など、さまざまな要因の影響を受けています。市場のイデオロギーに焦点を当て、成長を促進するためには、これらの要因を理解することが不可欠です。

脳イメージングモダリティ市場を牽引する要因は以下の通り：

• 技術の進歩：超高解像度MRIや人工知能統合などの革新的イメージング技術の開発が市場開拓に寄与しています。これらの技術は診断精度を向上させ、脳研究や臨床における新たな応用を可能にします。
• 神経疾患患者の増加：アルツハイマー病やパーキンソン病などの神経疾患の罹患率が上昇していることが、先進的な脳画像診断装置に対する需要の増加に寄与しています。この動向は新たなイメージング技術の開発を必要としています。
• 政府資金と研究助成金：神経科学と関連する脳イメージングに対する政府資金と研究助成金の増加は、新技術の開発を可能にしています。このような資金援助により、脳画像分野での技術革新が加速しています。
• 意識の高まりと早期診断：神経疾患の早期診断と予防医療への関心が高まる傾向があります。こうした意識の高まりと早期発見の提唱が、高度な脳画像技術の必要性を後押ししています。
• AIと機械学習の統合：人工知能と機械学習の活用により、脳画像技術のデータ解釈能力が向上しています。これらの進歩は、より優れた画像解析とより効果的な診断につながります。

脳イメージングモダリティ市場における課題は以下の通り：

• 先進イメージングシステムの高コスト：7T MRIのような先進的画像診断システムの法外な価格は、その普及を阻む大きな障壁となっています。この課題は患者とヘルスケアサービス提供者の双方に影響し、最新画像技術の適用を制限しています。
• 規制と承認のハードル：新しい画像システムの臨床評価と承認は、既存の規制のために困難な場合が多いです。これらの障壁は、革新的なソリューションを市場に導入するスケジュールを遅らせる可能性があります。
• データプライバシーとセキュリティへの懸念：脳画像処理による個人医療情報の取得と保持は、プライバシーとセキュリティに関する懸念を引き起こします。個人データの保護と患者のプライバシー法の尊重は、対処すべき重要な問題です。

脳イメージングモダリティ市場は、先端技術、診断支援に対する需要、コスト、政策、データセキュリティに関する新たな問題により変化を経験しています。これらの促進要因と課題を理解することは、この分野の目標を達成し、患者に利益をもたらすために不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 世界の脳イメージングモダリティ市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界の脳イメージングモダリティ市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界の脳イメージングモダリティ市場：製品別
  • CT装置
  • MRI装置
  • PET装置
  • PET-CT装置
  • PET-MRI装置
• 世界の脳イメージングモダリティ市場：患者の種類別
  • 成人・児童
  • 乳児
• 世界の脳イメージングモダリティ市場：最終用途別
  • 病院・診療所
  • 画像診断センター
  • 外来手術センター

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界の脳イメージングモダリティ市場：地域別
• 北米の脳イメージングモダリティ市場
• 欧州の脳イメージングモダリティ市場
• アジア太平洋の脳イメージングモダリティ市場
• その他地域の脳イメージングモダリティ市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の脳イメージングモダリティ市場の成長機会：製品別
  • 世界の脳イメージングモダリティ市場の成長機会：患者の種類別
  • 世界の脳イメージングモダリティ市場の成長機会：最終用途別
  • 世界の脳イメージングモダリティ市場の成長機会：地域別
• 世界の脳イメージングモダリティ市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の脳イメージングモダリティ市場の生産能力拡大
  • 世界の脳イメージングモダリティ市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Aspect Imaging
• Canon
• Esaote
• Fujifilm Holdings Corporation
• General Electric

The future of the global brain imaging modalities market looks promising with opportunities in the hospital & clinic, diagnostic imaging center, and ambulatory surgical center markets. The global brain imaging modalities market is expected to reach an estimated $18.5 billion by 2031 with a CAGR of 4.8% from 2025 to 2031. The major drivers for this market are the growing prevalence of neurological disorders and traumatic brain injuries, ongoing technological advancements in brain imaging modalities and systems, and the rising popularity of molecular imaging in brain imaging.

• Lucintel forecasts that, within the product category, the MRI device is expected to witness the highest growth over the forecast period due to its increasing adoption to diagnose various medical conditions, such as brain tumors, strokes, and multiple sclerosis.
• Within the end use category, hospitals & clinics will remain the largest segment.
• In terms of region, North America will remain the largest region over the forecast period due to rising prevalence of neurological disorders, strong adoption of new technologies, and existence of leading brain imaging modalities manufacturers in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Brain Imaging Modalities Market

The brain imaging modalities market has exciting emerging trends that are transforming diagnostic and therapeutic strategies. These trends are supported by technological improvements, the application of AI, and a rising interest in precision medicine. Knowledge of such trends is important for stakeholders who want to maintain their competitiveness and innovativeness in the industry.

• Artificial Intelligence: Starting from charting the cerebral non-invasive imaging modalities, it's worthwhile to note that non-invasive stimulated cerebral high-resolution imaging has lagged behind imaging techniques targeting segments such as MRI/PET, computed tomography, and other examination techniques. However, AI algorithms are applied to improve vast quantitative imaging analyses, thus enabling the detection of subtle changes in brain structures that could take a long time to notice. Enhancements and modeling structures with the aid of AI in brain imaging modalities are advancing. Along with this trend, more tailored and effective interventions are expected to emerge.
• Development of Advanced MRI Technologies: The comparatively new ultra-high field scanners (7T MRI and above) provide remarkably more resolution and detail than their predecessors. This advancement has changed how brain anatomy and pathologies are rendered through imaging, enhancing the capabilities of such studies. This is of great significance in the diagnosis of complex neurological disorders and for research-based studies in neuroimaging.
• Multimodal Imaging: More frequently, advanced imaging techniques such as PET, MRI, and CT are utilized in combination. This method effectively marries structural and functional assessments within the brain, leading to a comprehensive understanding of neurological illnesses that allows for effective treatment management and follow-up.
• Portable Imaging Devices: Portable and compact imaging devices are gaining traction among neuroimaging practitioners in less privileged remote and rural regions. The design of these devices focuses on portability and simplicity of operation, offering useful diagnostic services in areas that are out of reach of hospitals.
• Concern for Degenerative Diseases: Recently, efforts have been made towards developing imaging systems appropriate for degenerative brain disorders like Alzheimer's and Parkinson's. New imaging technologies are helping to manage these diseases better, even at an early stage, thereby enhancing treatment options.

These trends are significantly impacting the brain imaging modalities market by increasing the clarity of diagnosis, widening accessibility, and encouraging creativity. Technologies will continue to develop, and refined methodologies will emerge in the realm of brain imaging as new frontiers in research and clinical practice are opened.

Recent Developments in the Brain Imaging Modalities Market

Some new trends in brain imaging modalities are revolutionizing imaging tools for diagnosis. Advances in innovation and progress in research are leading to improved, effective, and affordable brain imaging techniques.

• Imaging Software Improved with Artificial Intelligence: Numerous existing brain imaging techniques are enhancing the detection of brain diseases, thanks to new algorithms in AI imaging. This allows for quick analysis of sophisticated imaging data, facilitating same-day diagnosis of functional abnormalities within the nervous system.
• Available MRI Systems with Greater Resolution: The emergence of sophisticated systems, such as 7T MRI systems, has improved imaging capabilities. The increased detail of both normal and abnormal brain morphology enhances basic science and clinical pathological assessments.
• Various Imaging Techniques Employed: Newer imaging techniques, like PET scans coupled with MRI, are emerging. With such imaging, precise diagnosis and proper therapeutic decisions can be made when faced with diverse types of neuropathy.
• Imaging Technologies in the Field: Unfortunately, conventional imaging techniques are still limited, which widens the gap between where care is offered and where it is needed, especially with diseases such as stroke. These small systems provide necessary imaging modalities to cover the gaps in healthcare.
• Trends in Functional Imaging: Enhancements in dynamic imaging techniques such as fMRIs, PETs, and MRIs provide detailed information regarding processes and connections within the brain. These enhancements lead to a better understanding of how the brain functions and enable therapies to be developed in a targeted manner.

In conclusion, these developments are changing the brain imaging modalities market by making diagnosis efficient and creating user-friendly interfaces. The progress of various imaging technologies is proving beneficial to both research and practice in neuroscience.

Strategic Growth Opportunities for Brain Imaging Modalities Market

The brain imaging modalities market is full of strategic growth opportunities related to key applications dominating various submarkets. These can be effectively exploited for the benefit of innovation in diagnosis, treatment, and research.

• Neurodegenerative Disease Diagnosis: There is increasing scope for designing more sophisticated imaging systems that enable early diagnosis and monitoring of neurodegenerative diseases. Enhanced imaging may facilitate the diagnosis and treatment of neurological diseases, such as Alzheimer's and Parkinson's, well before the onset of symptoms.
• Personalized Medicine: As the trend shifts toward personalized medicine strategies, the integration of brain imaging with these approaches indicates a move toward custom treatments specific to individual brains. This creates a need for imaging systems that accurately depict a patient's condition and how they respond to therapies.
• Remote and Portable Imaging Solutions: There is a growing trend toward offering remote and portable brain imaging solutions, which can help reach underserved areas for diagnostic purposes. There is a need for affordable and user-friendly imaging systems in remote locations, presenting a significant market opportunity.
• Multimodal Imaging Integration: The ability to blend various imaging techniques for an all-encompassing evaluation of the brain holds much promise for development. Integrating instruments such as MRI, PET, and CT can improve diagnosis and, consequently, outcomes for patients.
• Research and Clinical Trials: Research and clinical trials in the area of brain imaging are being stepped up, providing room for improvements. Advances in developing imaging technologies will reduce the gaps in understanding brain function and in creating more effective treatment methods.

These strategic growth opportunities are shaping the future of the brain imaging modalities market. These areas must be prioritized for stakeholders to foster innovation, improve the diagnostic landscape, and enhance patient experience.

Brain Imaging Modalities Market Driver and Challenges

The brain imaging modalities market is influenced by a variety of factors, including technological improvements, economic changes, and regulatory policies. It is imperative to understand these factors to focus on the ideologies of the market and foster growth.

The factors driving the brain imaging modalities market include:

• Technological Advancements: The development of innovative imaging technologies, such as ultra-high-resolution MRI and artificial intelligence integration, contributes to market growth. These technologies improve diagnostic accuracy and enable new applications in brain research and clinical practice.
• Increased Patients with Neurological Disorders: The rising incidence of neurological disorders, such as Alzheimer's and Parkinson's diseases, is contributing to increased demand for advanced brain imaging devices. This trend necessitates the development of new imaging techniques.
• Government Funding and Research Grants: An increase in government funding and research grants for neuroscience and related brain imaging is enabling the development of new technologies. This funding accelerates innovation within the brain imaging field.
• Growing Awareness and Early Diagnosis: There is a trend of increasing interest in early diagnosis and preventive care for neurological disorders. This heightened awareness and advocacy for early detection are driving the need for sophisticated brain imaging techniques.
• Integration of AI and Machine Learning: The use of artificial intelligence and machine learning has enhanced data interpretation capabilities in brain imaging technologies. These advancements lead to better image analysis and more effective diagnoses.

Challenges in the brain imaging modalities market include:

• High Costs of Advanced Imaging Systems: The exorbitant price of advanced imaging systems, like the 7T MRI machine, is a significant barrier to their adoption. This challenge affects both patients and healthcare service providers, limiting the application of the latest imaging technologies.
• Regulatory and Approval Hurdles: Clinical evaluation and approval for novel imaging systems are often arduous due to existing regulations. These barriers can delay the timeline for introducing innovative solutions to the market.
• Data Privacy and Security Concerns: The acquisition and retention of personal medical information through brain imaging processes raise concerns regarding privacy and security. Protecting personal data and respecting patients' privacy laws are critical issues that must be addressed.

The brain imaging modalities market is experiencing a shift due to advanced technology, the demand for diagnostic assistance, and emerging issues related to cost, policies, and data security. Understanding these drivers and challenges is essential for achieving the goals of this field and benefiting patients.

List of Brain Imaging Modalities Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain imaging modalities companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain imaging modalities companies profiled in this report include-

• Aspect Imaging
• Canon
• Esaote
• Fujifilm Holdings Corporation
• General Electric

Brain Imaging Modalities by Segment

The study includes a forecast for the global brain imaging modalities market by product, patient type, end use, and region.

Brain Imaging Modalities Market by Product [Analysis by Value from 2019 to 2031]:

• CT Devices
• MRI Devices
• PET Devices
• PET-CT Devices
• PET-MRI Devices

Brain Imaging Modalities Market by Patient Type [Analysis by Value from 2019 to 2031]:

• Adults & Pediatrics
• Infants

Brain Imaging Modalities Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals & Clinics
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers

Brain Imaging Modalities Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Brain Imaging Modalities Market

Recently, the brain imaging modalities market has undergone radical changes due to new technologies, improved funding for research, and enhancements in healthcare systems. These changes are improving the means of diagnosis and treatment for brain disorders. Companies in major economies are advancing imaging technologies to provide quicker and more accurate diagnostic options.

• United States: Significant advancements have been made with the assistance of functional MRI (fMRI) and recently acquired advanced PET scanners in the U.S. Imaging is becoming faster and more precise as new algorithms incorporating AI are developed. Additionally, there is an increased use of multiple imaging modalities to enhance neuroimaging of the brain, leading to better diagnoses of neurodegenerative diseases and mental disorders.
• China: China is also progressing in brain imaging capabilities by focusing on improved MRI and PET technologies. Innovations include high-field MRI systems and high-resolution molecular imaging systems. Increased government support for neuroscience studies is facilitating the development of new imaging systems that enable more precise and earlier diagnoses of brain disorders.
• Germany: Germany is making strides in MRI technology, including the manufacture of 7T MRI machines that allow for better resolution during imaging. The development of imaging software systems, such as reconstruction algorithms, along with the integration of machine learning, is improving diagnostic performance. These advancements align with German policies emphasizing increased research and development regarding the complexity of brain structures and functions.
• India: India is advancing in brain imaging by utilizing enhanced MRI and CT scanning technologies. Efforts are being made to expand the geographical coverage of imaging facilities to provide high-standard services in both urban and rural areas. There is a growing focus on developing affordable imaging modalities to meet the needs of a diverse population, thereby improving diagnosis and treatment.
• Japan: Japan is developing new technologies for brain imaging, particularly in PET and MRI systems. The focus is on integrating imaging with artificial intelligence to improve diagnostic quality and subsequent treatment. As a nation that values technology and innovation, Japan is leveraging advancements for brain imaging across various neurological disorders.

Features of the Global Brain Imaging Modalities Market

Market Size Estimates: Brain imaging modalities market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Brain imaging modalities market size by product, patient type, end use, and region in terms of value ($B).

Regional Analysis: Brain imaging modalities market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, patient types, end uses, and regions for the brain imaging modalities market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain imaging modalities market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the brain imaging modalities market by product (CT devices, MRI devices, PET devices, PET-CT devices, and PET-MRI devices), patient type (adults & pediatrics and infants), end use (hospitals & clinics, diagnostic imaging centers, and ambulatory surgical centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Brain Imaging Modalities Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Brain Imaging Modalities Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Brain Imaging Modalities Market by Product
  • 3.3.1: CT Devices
  • 3.3.2: MRI Devices
  • 3.3.3: PET Devices
  • 3.3.4: PET-CT Devices
  • 3.3.5: PET-MRI Devices
• 3.4: Global Brain Imaging Modalities Market by Patient Type
  • 3.4.1: Adults & Pediatrics
  • 3.4.2: Infants
• 3.5: Global Brain Imaging Modalities Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Diagnostic Imaging Centers
  • 3.5.3: Ambulatory Surgical Centers

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Brain Imaging Modalities Market by Region
• 4.2: North American Brain Imaging Modalities Market
  • 4.2.1: North American Brain Imaging Modalities Market by Product: CT Devices, MRI Devices, PET Devices, PET-CT Devices, and PET-MRI Devices
  • 4.2.2: North American Brain Imaging Modalities Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, and Ambulatory Surgical Centers
• 4.3: European Brain Imaging Modalities Market
  • 4.3.1: European Brain Imaging Modalities Market by Product: CT Devices, MRI Devices, PET Devices, PET-CT Devices, and PET-MRI Devices
  • 4.3.2: European Brain Imaging Modalities Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, and Ambulatory Surgical Centers
• 4.4: APAC Brain Imaging Modalities Market
  • 4.4.1: APAC Brain Imaging Modalities Market by Product: CT Devices, MRI Devices, PET Devices, PET-CT Devices, and PET-MRI Devices
  • 4.4.2: APAC Brain Imaging Modalities Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, and Ambulatory Surgical Centers
• 4.5: ROW Brain Imaging Modalities Market
  • 4.5.1: ROW Brain Imaging Modalities Market by Product: CT Devices, MRI Devices, PET Devices, PET-CT Devices, and PET-MRI Devices
  • 4.5.2: ROW Brain Imaging Modalities Market by End Use: Hospitals & Clinics, Diagnostic Imaging Centers, and Ambulatory Surgical Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Brain Imaging Modalities Market by Product
  • 6.1.2: Growth Opportunities for the Global Brain Imaging Modalities Market by Patient Type
  • 6.1.3: Growth Opportunities for the Global Brain Imaging Modalities Market by End Use
  • 6.1.4: Growth Opportunities for the Global Brain Imaging Modalities Market by Region
• 6.2: Emerging Trends in the Global Brain Imaging Modalities Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Brain Imaging Modalities Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Imaging Modalities Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Aspect Imaging
• 7.2: Canon
• 7.3: Esaote
• 7.4: Fujifilm Holdings Corporation
• 7.5: General Electric